Divi's Labs gains 5% on strong Q3 performance

Shares of Divi's Laboratories surged 5 per cent to close at Rs 5,889 on February 3, 2025, after the company reported a robust set of numbers for Q3 FY25. The pharmaceutical major posted a revenue of Rs 2,319 crore, reflecting a 25 per cent jump from Rs 1,855 crore in the same quarter last year. Net profit also saw a strong uptick, rising 65 per cent year-on-year to Rs 589 crore.